California Public Employees Retirement System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-54,226
Closed -$1.43M 1268
2021
Q4
$1.43M Sell
54,226
-2,229
-4% -$172K ﹤0.01% 1218
2021
Q3
$5.68M Hold
56,455
﹤0.01% 1179
2021
Q2
$7.99M Sell
56,455
-34,468
-38% -$3.89M 0.01% 1131
2021
Q1
$9.06M Buy
90,923
+39,492
+77% +$4.61M 0.01% 1134
2020
Q4
$6.36M Buy
51,431
+947
+2% +$124K ﹤0.01% 1283
2020
Q3
$4.92M Sell
50,484
-2,597
-5% -$324K ﹤0.01% 1245
2020
Q2
$8.28M Buy
53,081
+2,504
+5% +$381K 0.01% 913
2020
Q1
$7.3M Sell
50,577
-19,970
-28% -$3.86M 0.01% 827
2019
Q4
$14.4M Buy
70,547
+33,428
+90% +$6.1M 0.01% 744
2019
Q3
$2.98M Buy
37,119
+4,384
+13% +$372K ﹤0.01% 1634
2019
Q2
$3.09M Sell
32,735
-266
-0.8% -$23K ﹤0.01% 1419
2019
Q1
$2.82M Buy
33,001
+4,498
+16% +$373K ﹤0.01% 1552
2018
Q4
$1.6M Buy
28,503
+25,000
+714% +$1.53M ﹤0.01% 1876
2018
Q3
$286K Buy
+3,503
New +$247K ﹤0.01% 2898

Other funds holding RETA

California Public Employees Retirement System's RETA Position: Q1 2022 in Review

California Public Employees Retirement System sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2022, closing a stake of 54,226 shares — an estimated $1.43M sold.

California Public Employees Retirement System first reported a position in RETA in Q3 2018 and held it in 14 quarters. The position peaked at $14.4M in Q4 2019. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.

  • California Public Employees Retirement System reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • California Public Employees Retirement System sold 54,226 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.43M.
  • California Public Employees Retirement System first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and held it in 14 quarters.
  • California Public Employees Retirement System's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $14.4M in Q4 2019.
  • 149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.

Based on California Public Employees Retirement System's 13F filing for Q1 2022, filed 4 May 2022.